2023-11-17, Pekacka-Egli, Anna Maria, Bujan, Magdalena, Disko, Andreas, Lutz, Dietmar, Spielmanns, Marc, Kolbm, Benjamin, Bujanm Bartosz

2021, Pekacka-Egli, Anna Maria, Baj-Lieder, Marty, Ulman-Bogusławska, Renata

2020, Hermann, Matthias, Pekacka-Egli, Anna Maria, Witassek, Fabienne, Baumgaertner, Reiner, Schoendorf, Sabine, Spielmanns, Marc

Abstract The COVID-19 pandemic affects a large number of patients with a rapid progression of respiratory failure often requiring hospitalization or intensive care unit treatment in some patients. Survivors of severe COVID-19 experience persistent weakness and cardiorespiratory failure. Feasibility and potential benefit of cardiopulmonary rehabilitation after COVID-19 remains unclear. Therefore, we retrospectively analyzed a cohort of COVID-19 patients in a single-center inpatient rehabilitation clinic and describe performance and outcome during cardiopulmonary rehabilitation. Patients were referred from acute care hospitals for rehabilitation after severe COVID-19. The cohort (N = 28) was divided in ventilated or not ventilated patients for further analysis. Fifty percent were female, the mean age was 66 yrs, and patients stayed in the acute hospital for 19.3 ± 10.7 days before referral for cardiopulmonary rehabilitation. Seventeen patients (61%) needed previous intensive care unit treatment in the acute care hospital. Risk factors, assessments, and questionnaires on admission were comparable in both groups. Significant enhancements were observed in 6-min walking test and feeling thermometer, which were independent of previous ventilation status. In conclusion, comprehensive cardiopulmonary rehabilitation after COVID-19 is safe, feasible, and effective. Improvements in physical performance and subjective health status were independent of previous ventilation.

2021, Pekacka-Egli, Anna Maria

2021, Spielmanns, Marc, Böselt, Tobias, Huber, Stephan, Bollinger, Pawandeep Kaur, Bjoerklund, Jonas, Ulm, Bernhard, Pekacka-Egli, Anna Maria, Leitl, Daniela, Jarosch, Inga, Schneeberger, Tessa, Spielmanns, Sabine, Gloeckl, Rainer, Koczulla, Rembert

2018, Pekacka-Egli, Anna Maria, Uniwersytet Rzeszowski

2021, Pekacka-Falkowska, Katarzyna, Pekacka-Egli, Anna Maria

2021, Spielmanns, Marc, Pekacka-Egli, Anna Maria, Cecon, Mikis, Witassek, Fabienne, Schoendorf, Sabine, Lutz, Dietmar, Hermann, Matthias

Objective The COVID-19 pandemic affects a large number of patients. The impact on feasibility and outcome of rehabilitation during COVID-19 actually remains unclear. Nosocomial infection of healthcare workers or hospitalized patients is common, and prevention of nosocomial infections during rehabilitation is challenging. Therefore, we analyzed a cohort of nosocomial infected COVID-19 patients in a single-center inpatient rehabilitation clinic and described performance and outcome. Design The cohort describes patients with nosocomial SARS-CoV-2 infection while participating in neuromusculoskeletal rehabilitation. Infection was caused by an initially unidentified so-called superspreader. We compared this cohort with all neuromusculoskeletal rehabilitation inpatients of 2019 (comparison group). Normally distributed continuous variables were presented as mean with standard deviation and the test was used for comparison between groups. Linear regression was used to assess the impact of COVID-19 on Functional Independence Measure at discharge. Results COVID-19 patients were mostly male (66.7%) with an age of 71.5 ± 12.3 yrs. Age, sex, and cumulated comorbidities of the comparison group were not different from the COVID-19 group. A total of 92.6% of COVID-19 patients had a mild or moderate course, two patients had to be referred to acute hospital because of respiratory failure, and one of these patients died in the acute hospital. After implementation of a strict hygiene concept, no further nosocomial COVID-19 infections were detected. The rehabilitation duration was significantly longer in the COVID-19 group (54.2 ± 23.6 days vs. 32.1 ± 17.7 days. Daily therapy duration was 132.3 ± 44 mins before SARS-CoV-2 infection and reduced to 81.9 ± 27.3 mins during COVID-19. After discontinuation of isolation measures, therapy duration increased significantly (99.3 ± 70.2 mins). The baseline Functional Independence Measure score was higher in the COVID-19 group (91.93 ± 25.64 points vs. 82.98 ± 22.73 points) and Functional Independence Measure improvements were lower in COVID-19 patients than in the 2019 comparison group (6.96 ± 8.96 points vs. 20.3 ± 15.98 pointslt; 0.001). COVID-19 infection itself had a strong negative impact on Functional Independence Measure change as identified by regression analysis. Linear regression analysis showed that COVID-19 reduced the Functional Independence Measure at discharge by 8.9 points (95% CI = −14.725 to −3.097, P = 0.003) after correction for Functional Independence Measure at admission, age, sex, and morbidity index at admission. Conclusions COVID-19 had a strong negative impact on rehabilitation benefits as assessed by Functional Independence Measure. Neuromusculoskeletal rehabilitation could be continued, but all patients received less therapy minutes during isolation. After implementation of a strict COVID-19–specific hygiene concept, no further infections were detected.

2017, Pekacka-Egli, Anna Maria, Uniwersytet Rzeszowski